Tris Pharma Spending Nearly $3 Million on New Jersey Plant Expansion

---

Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). Tris Pharma, Incorporated (Monmouth Junction, New Jersey) is expanding its research and manufacturing facility, which is located in the Brunswick Business Park in Monmouth Junction, New Jersey. (Plant 1063006) The company is spending $2.9 million on the expansion, which will renovate and equip 20,800 square feet of space.

The New Jersey Economic Development Authority (EDA) is assisting with the expansion in the form of low-cost, tax-exempt bond financing. The 10-year bond is backed by a 50% EDA guarantee. The EDA also provided Tris with financial help when the company first moved into the business park in 2002.

Tris develops and patents drug delivery technologies for a variety of existing and new pharmaceutical products, to deliver drugs faster and more effectively. The company anticipates hiring an additional 20-40 people when the project is fully completed later this year.

Click the following link to view Industrialinfo.com's new 2004 North American Pharmaceutical-Biotech Forecast and the entire Pharmaceutical-Biotech Database.